Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Fall;13(4):1295-301.

Effect of Dietary Ethanolic Extract of Lavandula officinalis on Serum Lipids Profile in Rats

Affiliations

Effect of Dietary Ethanolic Extract of Lavandula officinalis on Serum Lipids Profile in Rats

Zahra Rabiei et al. Iran J Pharm Res. 2014 Fall.

Abstract

Antioxidants are effective in prevention and treatment of cardiovascular diseases. Lavandula officinalis possesses antioxidant activity, therefore, in this study; the effects of Lavandula officinalis extract were investigated on serum lipids levels of rats. Experimental mature male Wistar rats were treated with 100, 200 or 400 mg/Kg/day of lavender ethanolic extract or distilled water for 25 days via gastric gavage (n=8 each group). At the end of 25(th) day, the serum cholesterol, triglyceride, HDL, LDL and VLDL levels, as well as atherogenic indices were determined in rats' serum. The ethanolic extract of lavender decreased serum cholesterol, triglyceride, LDL and VLDL levels in 100 mg/Kg group (p=0.03, p=0.001, p=0.001, p=0.001, respectively). Serum HDL level increased in 100 mg/Kg/day group (p=0.01). Lavender extract decreased LDL/HDL level at doses of 100 and 200 mg/Kg/day (p=0.001, p=0.001, respectively). The TG/HDL levels decreased in experimental groups with doses of 100 and 200 mg/Kg/day (p=0.001, p=0.001, respectively). Lavandula officinalis extract exerts hypolipidemic effect in rats and might be beneficial in hyperlipidemic patients.

Keywords: Atherogenic index; Cardiovascular; Lavandula officinalis; Serum lipids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum lipids levels (mg/dl) (**=P < 0.05; ***=P < 0.01) n=8
Figure 2
Figure 2
Serum LDL/HDL and TG/HDL levels. (***=P < 0.01) (n=8).

References

    1. Keys A. Coronary heart disease in seven countries. Nutr. 1997;13:250–252. - PubMed
    1. Asgary S, Kelishadi R, Rafieian-Kopaei M, Najafi S, Najafi M, Sahebkar A. Investigation of the lipid-modifying and antiinflammatory effects of Cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatr Cardiol. 2013;34:1729–1735. - PubMed
    1. Gharipour M, Ramezani MA, Sadeghi M, Khosravi A, Masjedi M, Khosravi-Boroujeni H, Rafieian-Kopaei M, Sarrafzadegan N. Sex based levels of Creactive protein and white blood cell count in subjects with metabolic syndrome: Isfahan Healthy Heart Program. J. Res. Med. Sci. 2013;18:467–472. - PMC - PubMed
    1. Setorki , M , Nazari B, Asgary S, Azadbakht L, Rafieian-Kopaei M. Anti atherosclerotic effects of verjuice on hypocholesterolemic rabbits. Afr. J. Pharm. Pharmacol. 2011;5:1038–1045.
    1. Jeffrey L, Anderson , Cynthia D Adams, Elliott M Antman, Charles R Bridges, Donald E Casey, William E Chavey II, Francis M Fesmire, Judith S Hochman, Thomas N Levin, A Michael Lincoff, Eric D Peterson, Pierre Theroux, Nanette Kass Wenger, R Scott Wright. ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction executive summarya report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J. Am. Coll. Cardiol. 2004;44:671–719. - PubMed

LinkOut - more resources